A decision tree model in pharmacoeconomic evaluation of surgical and endovascular treatment of intracranial aneurysms
DOI:
https://doi.org/10.24959/cphj.15.1352Keywords:
cerebral aneurysm, surgical and endovascular treatment, alternative therapyAbstract
Endovascular [coil] treatment is being used as an alternative to surgical treatment [clipping] for intracranial aneurysms. The purpose of this study was to compare the endovascular treatment and surgical clipping by cost-effectiveness and cost-utility analyses and applying analytical "decision tree" model. The study included 124 patients with intracranial aneurysms from November 2010 to November 2011 (90 underwent surgical clipping, whereas 34 were treated via coiling). Clinical outcome at the 6th month, using the Glasgow Outcome Scale (GOS), and cost of treatment, as well as the quality-adjusted life year (QALY) were evaluated in both groups. In GOS 4 and 5 they were 91.2% of the group treated via coiling and 81.1% of surgically treated patients. Health conditioned quality of life for the first year in 106 patients was: 0,844 QALY for endovascular treatment (27 patients) and 0,737 QALY (79 patients) for surgical treatment. The average cost for patients undergoing endovascular treatment of aneurysms in BGN is estimated at 19,856 while the average price of surgery in BGN is 11,480. There is no statistically significant difference in clinical outcome at the sixth month and in the health conditioned quality of life for the first year after the treatment in both groups. Patients in the endovascular group have had higher rates of intervention than the patients from the surgical group, due to the cost of consumables.
References
Hashimoto T., Meng H., Young W.L. // Neurological Res. – 2006. – Vol. 28, №4. – P. 372-380.
Jennett B., Bond M. // Lancet. – 1975. – Vol. 1. – P. 480-484.
Krex D., Schackert H.K., Schackert G. // Acta Neurochirurgica. – 2001. – Vol. 143, №5. – P. 429-449.
Wolstenholme J., Rivero-Arias O. // Stroke. – 2008. – Vol. 39. – P. 111-119.
http://www.euroqol.org/eq-5d-products/how-to-obtain-eq-5d.html
Downloads
Published
Issue
Section
License
Copyright (c) 2015 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
